Document Detail


Uterine artery embolization for the treatment of fibroids.
MedLine Citation:
PMID:  12195604     Owner:  HSR     Status:  MEDLINE    
Abstract/OtherAbstract:
Uterine artery embolization (UAE), or uterine fibroid embolization, is a non-surgical treatment for uterine fibroids that preserves the uterus and offers women an alternative to surgical procedures such as hysterectomy and myomectomy. Evidence from controlled trials comparing fibroid treatments is not yet available. Case series reports indicate that UAE is a relatively safe and effective treatment for symptomatic fibroids. The effect of UAE on fertility and pregnancy is not known, though pregnancies following UAE have been reported. UAE may reduce health care costs associated with treating fibroids through shorter hospital stays and faster recoveries.
Authors:
Leigh-Ann Topfer; David Hailey
Related Documents :
12423824 - Rupture of noncommunicating rudimentary uterine horn pregnancy.
17212904 - Laparoscopic management of rudimentary uterine horn pregnancy: case report and literatu...
22325554 - Hypotension after medical termination of pregnancy: think outside of the uterus.
18752884 - Inhibitory effects of electrical stimulation on delivery in pregnant rats.
9660424 - Induction of spermatogenesis and achievement of pregnancy after microsurgical varicocel...
3904324 - Amniocentesis in treatment of acute polyhydramniosis in twin pregnancies.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Issues in emerging health technologies     Volume:  -     ISSN:  1488-6316     ISO Abbreviation:  Issues Emerg Health Technol     Publication Date:  2002 Aug 
Date Detail:
Created Date:  2002-08-26     Completed Date:  2002-08-30     Revised Date:  2010-01-22    
Medline Journal Info:
Nlm Unique ID:  100886782     Medline TA:  Issues Emerg Health Technol     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  1-6     Citation Subset:  T    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Canada
Costs and Cost Analysis
Device Approval
Embolization, Therapeutic / adverse effects,  economics,  methods*
Female
Humans
Leiomyoma / therapy*
Patient Satisfaction
Randomized Controlled Trials as Topic
Technology Assessment, Biomedical
United States
United States Food and Drug Administration
Uterine Neoplasms / therapy*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Tiotropium: a potential replacement for ipratropium in patients with COPD.
Next Document:  Fondaparinux for post-operative venous thrombosis prophylaxis.